Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
A Phase 2 Study of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Rheumatoid Arthritis Inadequately Responding to Biological Disease-Modifying Antirheumatic Drugs
Always swirl gently or allow passive dissolution
IGF-LR3 Canada is supplied as 1mg lyophilized material in a 3 mL glass vial
(PMID 8669775)
BPC-157, a gastric pentadecapeptide derived from proteolytic enzyme preparations, and TB-500, a synthetic analogue of thymosin beta-4, represent emerging agents with broad biological activity relevant to tissue repair and cytoprotection
US$ 25.79
US$ 23.75
US$ 29.44
US$ 28.04
US$ 26.65
US$ 22.28
